A new and growing market for weight-loss drugs in India is expected to be a bright spot for pharmaceutical firms like Cipla Ltd. and Dr Reddy’s Laboratories Ltd., while they face headwinds in the US market.
Source: Bloomberg Markets — This article was automatically imported from the source. Read full article at original source →
